Miranda T Schram Selected Research

Prediabetic State (Prediabetes)

1/2022	Health burden in type 2 diabetes and prediabetes in The Maastricht Study.
1/2022	Sedentary behaviour and physical activity are associated with biomarkers of endothelial dysfunction and low-grade inflammation-relevance for (pre)diabetes: The Maastricht Study.
1/2022	Prevalent Morphometrically Assessed Vertebral Fractures in Individuals With Type 2 Diabetes, Prediabetes and Normal Glucose Metabolism: The Maastricht Study.
11/2021	Associations between plasma kynurenines and cognitive function in individuals with normal glucose metabolism, prediabetes and type 2 diabetes: the Maastricht Study.
1/2021	Sex differences in the association of prediabetes and type 2 diabetes with microvascular complications and function: The Maastricht Study.
1/2021	Habitual Intake of Dietary Advanced Glycation End Products Is Not Associated with Arterial Stiffness of the Aorta and Carotid Artery in Adults: The Maastricht Study.
1/2021	Machine learning-based glucose prediction with use of continuous glucose and physical activity monitoring data: The Maastricht Study.
2/2020	Reduced corneal nerve fibre length in prediabetes and type 2 diabetes: The Maastricht Study.
1/2020	White Matter Connectivity Abnormalities in Prediabetes and Type 2 Diabetes: The Maastricht Study.
1/2020	Both Prediabetes and Type 2 Diabetes Are Associated With Lower Heart Rate Variability: The Maastricht Study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Miranda T Schram Research Topics

Disease

48	Type 2 Diabetes Mellitus (MODY) 01/2022 - 02/2004
20	Prediabetic State (Prediabetes) 01/2022 - 11/2016
14	Cardiovascular Diseases (Cardiovascular Disease) 10/2020 - 02/2004
13	Albuminuria 01/2022 - 01/2006
8	Inflammation (Inflammations) 01/2022 - 07/2003
8	Hyperemia 01/2022 - 08/2015
8	Insulin Resistance 01/2021 - 03/2013
6	Glucose Intolerance 01/2022 - 12/2012
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 04/2016
4	Cerebral Small Vessel Diseases 01/2020 - 01/2017
4	Hypertension (High Blood Pressure) 01/2020 - 11/2008
3	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021 - 08/2015
3	Depressive Disorder (Melancholia) 01/2017 - 01/2016
2	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2022
2	Cognitive Dysfunction 11/2021 - 01/2017
2	Diabetes Mellitus 01/2021 - 04/2016
2	Stroke (Strokes) 01/2021 - 11/2008
2	Myocardial Infarction 01/2021 - 04/2016
2	Diabetes Complications 01/2018 - 11/2012
2	Chronic Renal Insufficiency 01/2018 - 02/2017
2	Hyperglycemia 11/2017 - 11/2016
2	Obesity 12/2014 - 03/2013
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2013 - 07/2005
1	Feeding and Eating Disorders (Eating Disorder) 06/2021
1	Sleep Initiation and Maintenance Disorders (Insomnia) 06/2021
1	Mental Disorders (Mental Disorder) 06/2021
1	Anxiety Disorders (Anxiety Disorder) 06/2021
1	Heart Failure 01/2021
1	Hypoglycemia (Reactive Hypoglycemia) 01/2020
1	Neuralgia (Stump Neuralgia) 01/2020
1	Lacunar Stroke 01/2020
1	Brain Ischemia (Cerebral Ischemia) 01/2019
1	Migraine Disorders (Migraine) 01/2019
1	Cysts 11/2018
1	Epiretinal Membrane (Epiretinal Membranes) 11/2018
1	Retinal Perforations 11/2018
1	Infections 01/2018
1	Communicable Diseases (Infectious Diseases) 01/2018
1	Infarction (Infarctions) 01/2017

Drug/Important Bio-Agent (IBA)

40	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 02/2004
16	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2012
15	Retinaldehyde (Retinal)IBA 01/2022 - 08/2015
7	LipidsIBA 10/2020 - 08/2015
6	Advanced Glycation End ProductsIBA 01/2021 - 07/2003
6	Triglycerides (Triacylglycerol)IBA 01/2020 - 07/2003
5	Antihypertensive Agents (Antihypertensives)IBA 10/2020 - 08/2015
4	E-SelectinIBA 01/2022 - 07/2003
4	CholesterolIBA 01/2022 - 01/2017
4	SelectinsIBA 01/2022 - 01/2020
4	von Willebrand FactorIBA 01/2022 - 01/2020
4	HDL CholesterolIBA 01/2020 - 07/2003
4	Insulin (Novolin)FDA Link 01/2020 - 03/2013
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2021 - 11/2016
3	Uric Acid (Urate)IBA 10/2017 - 08/2015
3	pentosidineIBA 01/2017 - 07/2003
3	C-Reactive ProteinIBA 08/2016 - 03/2007
3	Immunoglobulin M (IgM)IBA 01/2016 - 02/2004
2	FructoseIBA 01/2022 - 04/2017
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 01/2019
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2020 - 01/2017
2	HDL LipoproteinsIBA 01/2019 - 01/2019
2	CreatinineIBA 01/2018 - 02/2017
2	Cystatin CIBA 01/2018 - 02/2017
2	AlbuminsIBA 01/2018 - 12/2016
2	Blood Glucose (Blood Sugar)IBA 09/2016 - 05/2015
1	Dietary Fiber FDA Link 01/2022
1	Vitamin E FDA LinkGeneric 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Kynurenic Acid (Kynurenate)IBA 11/2021
1	KynurenineIBA 11/2021
1	3-hydroxykynurenineIBA 11/2021
1	xanthurenic acidIBA 11/2021
1	3-Hydroxyanthranilic AcidIBA 11/2021
1	Antipsychotic Agents (Antipsychotics)IBA 06/2021
1	Antidepressive Agents (Antidepressants)IBA 06/2021
1	Dietary Advanced Glycation End ProductsIBA 01/2021
1	N(6)-carboxymethyllysine (carboxymethyllysine)IBA 01/2021
1	LDL CholesterolIBA 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2020
1	Lipoproteins (Lipoprotein)IBA 01/2019
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2019
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	A-factor (Streptomyces)IBA 01/2019
1	Adenosine Triphosphate (ATP)IBA 12/2018
1	Complement System Proteins (Complement)IBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2017
1	Sucrose (Saccharose)IBA 04/2017
1	Syntex adjuvant formulationIBA 01/2017
1	Troponin IIBA 01/2017
1	Protons (Proton)IBA 09/2016
1	gamma-Aminobutyric Acid (GABA)IBA 09/2016
1	Neurotransmitter Agents (Neurotransmitter)IBA 09/2016
1	TroponinIBA 04/2016
1	trans-crotonin (CTN)IBA 04/2016

Therapy/Procedure

3	Glycemic Control 11/2021 - 07/2003
2	Therapeutics 01/2020 - 10/2007
1	Traction 11/2018
1	Lasers (Laser) 11/2016